Synthetic biology triggers new era of antibiotics development

Subcellular Biochemistry

Volumn 64, Issue , 2012, Pages 95-114

  Wang, Jianfeng ^a   Xiong, Zhiqiang ^a   Meng, Hailin ^a   Wang, Yiguang ^b   Wang, Yong ^a  

^a INSTITUTE OF PLANT PHYSIOLOGY AND ECOLOGY   (China)

^b INSTITUTE OF MEDICINAL BIOTECHNOLOGY   (China)

Author keywords

Antibiotics screening; Environmental DNA; Heterologous biosynthesis; Synthetic biology; Systematic engineering

Indexed keywords

ANTIINFECTIVE AGENT; BIOLOGICAL PRODUCT;

ANIMAL; BIOSYNTHESIS; DRUG DEVELOPMENT; DRUG SCREENING; GENETIC ENGINEERING; HUMAN; METABOLISM; METHODOLOGY; REVIEW; SYNTHETIC BIOLOGY;

ANIMALS; ANTI-BACTERIAL AGENTS; BIOLOGICAL PRODUCTS; DRUG DISCOVERY; DRUG EVALUATION, PRECLINICAL; GENETIC ENGINEERING; HUMANS; SYNTHETIC BIOLOGY;

EID: 84875765189     PISSN: 03060225     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-94-007-5055-5_5     Document Type: Article

References (120)

1. Agapakis CM, Silver PA (2009) Synthetic biology: exploring and exploiting genetic modularity through the design of novel biological networks. Mol Biosyst 5: 704-713.
2. Ajikumar PK, Xiao WH, Tyo KE, Wang Y, Simeon F, Leonard E, Mucha O, Phon TH, Pfeifer B, Stephanopoulos G (2010) Isoprenoid pathway optimization for taxol precursor overproduction in Escherichia coli. Science 330: 70-74.
3. Alper H, Fischer C, Nevoigt E, Stephanopoulos G (2005a) Tuning genetic control through promoter engineering. Proc Natl Acad Sci U S A 102: 12678-12683.
4. Alper H, Miyaoku K, Stephanopoulos G (2005b) Construction of lycopene-overproducing E. coli strains by combining systematic and combinatorial gene knockout targets. Nat Biotechnol 23: 612-616.
5. Anthony JR, Anthony LC, Nowroozi F, Kwon G, Newman JD, Keasling JD (2009) Optimization of the mevalonate-based isoprenoid biosynthetic pathway in Escherichia coli for production of the anti-malarial drug precursor amorpha-4, 11-diene. Metab Eng 11: 13-19.
6. Aubel D, Morris R, Lennon B, Rimann M, Kaufmann H, Folcher M, Bailey JE, Thompson CJ, Fussenegger M (2001) Design of a novel mammalian screening system for the detection of bioavailable, non-cytotoxic streptogramin antibiotics. J Antibiot 54: 44-55.
7. Baltz RH (2006) Molecular engineering approaches to peptide, polyketide and other antibiotics. Nat Biotechnol 24: 1533-1540.
8. Baltz RH (2010) Streptomyces and saccharopolyspora hosts for heterologous expression of secondary metabolite gene clusters. J Ind Microbiol Biotechnol 37: 759-772.
9. Banik JJ, Brady SF (2010) Recent application of metagenomic approaches toward the discovery of antimicrobials and other bioactive small molecules. Curr Opin Microbiol 13: 603-609.
10. Barrett CL, Kim TY, Kim HU, Palsson BO, Lee SY (2006) Systems biology as a foundation for genome-scale synthetic biology. Curr Opin Biotechnol 17: 488-492.
11. Becker SA, Palsson BO (2005) Genome-scale reconstruction of the metabolic network in staphylococcus aureus N315: an initial draft to the two-dimensional annotation. BMC Microbiol 5: 8.
12. Becker SA, Feist AM, Mo ML, Hannum G, Palsson BO, Herrgard MJ (2007) Quantitative prediction of cellular metabolism with constraint-based models: the COBRA toolbox. Nat Protoc 2: 727-738.
13. Beven L, Castano S, Dufourcq J, Wieslander A, Wroblewski H (2003) The antibiotic activity of cationic linear amphipathic peptides: lessons from the action of leucine/lysine copolymers on bacteria of the class mollicutes. Eur J Biochem 270: 2207-2217.
14. Blasiak LC, Clardy J (2009) Discovery of 3-formyl-tyrosine metabolites from pseudoalteromonas tunicata through heterologous expression. J Am Chem Soc 132: 926-927.
15. Blunt JW, Copp BR, Munro MH, Northcote PT, Prinsep MR (2010) Marine natural products. Nat Prod Rep 27: 165-237.
16. Boghigian BA, Lee K, Pfeifer BA (2009) Computational analysis of phenotypic space in heterologous polyketide biosynthesis-applications to Escherichia coli, Bacillus subtilis, and Saccharomyces cerevisiae. J Theor Biol 262: 197-207.
17. Borisova SA, Zhao L, Melancon IC, Kao CL, Liu HW (2004) Characterization of the glycosyltransferase activity of desVII: analysis of and implications for the biosynthesis of macrolide antibiotics. J Am Chem Soc 126: 6534-6535.
18. Bromley EH, Channon K, Moutevelis E, Woolfson DN (2008) Peptide and protein building blocks for synthetic biology: from programming biomolecules to self-organized biomolecular systems. ACS Chem Biol 3: 38-50.
19. Bugl H, Danner JP, Molinari RJ, Mulligan JT, Park H-O, Reichert B, Roth DA, Wagner R, Budowle B, Scripp RM, Smith JAL, Steele SJ, Church G, Endy D (2007) DNA synthesis and biological security. Nat Biotechnol 25: 627-629.
20. Caboche S, Pupin M, Leclere V, Fontaine A, Jacques P, Kucherov G (2008) NORINE: a database of nonribosomal peptides. Nucleic Acids Res 36: D326-331.
21. Caboche S, Pupin M, Leclere V, Jacques P, Kucherov G (2009) Structural pattern matching of nonribosomal peptides. BMC Struct Biol 9: 15.
22. Caboche S, Leclère V, Pupin M, Kucherov G, Jacques P (2010) Diversity of monomers in nonribosomal peptides: towards the prediction of origin and biological activity. J Bacteriol 192: 5143-5150.
23. Chang MC, Eachus RA, Trieu W, Ro DK, Keasling JD (2007) Engineering Escherichia coli for production of functionalized terpenoids using plant P450s. Nat Chem Biol 3: 274-277.
24. Choi HS, Lee SY, Kim TY, Woo HM (2010) In silico identification of gene amplification targets for improvement of lycopene production. Appl Environ Microbiol 76: 3097-3105.
25. Clomburg JM, Gonzalez R (2010) Biofuel production in Escherichia coli: the role of metabolic engineering and synthetic biology. Appl Microbiol Biotechnol 86: 419-434.
26. Craig JW, Chang F-Y, Brady SF (2009) Natural products from environmental DNA hosted in ralstonia metallidurans. ACS Chem Biol 4: 23-28.
27. Craig JW, Chang F-Y, Kim JH, Obiajulu SC, Brady SF (2010) Expanding small-molecule functional metagenomics through parallel screening of broad-host-range cosmid environmental DNA libraries in diverse proteobacteria. Appl Environ Microbiol 76: 1633-1641.
28. De Mey M, Maertens J, Boogmans S, Soetaert WK, Vandamme EJ, Cunin R, Foulquie-Moreno MR (2010) Promoter knock-in: a novel rational method for thefine tuning of genes. BMC Biotechnol 10: 26.
29. Devasahayam G, Scheld WM, Hoffman PS (2010) Newer antibacterial drugs for a new century. Expert Opin Investig Drugs 19: 215-234.
30. Duarte NC, Herrgard MJ, Palsson BO (2004) Reconstruction and validation of Saccharomyces cerevisiae iND750, a fully compartmentalized genome-scale metabolic model. Genome Res 14: 1298-1309.
31. Duarte NC, Becker SA, Jamshidi N, Thiele I, Mo ML, Vo TD, Srivas R, Palsson BO (2007) Global reconstruction of the human metabolic network based on genomic and bibliomic data. Proc Natl Acad Sci U S A 104: 1777-1782.
32. Edwards JS, Palsson BO (2000) Metabolicflux balance analysis and the in silico analysis of Escherichia coli K-12 gene deletions. BMC Bioinform 1: 1.
33. Erb A, Weiss H, Harle J, Bechthold A (2009) A bacterial glycosyltransferase gene toolbox: generation and applications. Phytochemistry 70: 1812-1821.
34. Feist AM, Henry CS, Reed JL, Krummenacker M, Joyce AR, Karp PD, Broadbelt LJ, Hatzimanikatis V, Palsson BO (2007) A genome-scale metabolic reconstruction for Escherichia coli K-12 MG1655 that accounts for 1260 ORFs and thermodynamic information. Mol Syst Biol 3: 121.
35. Feng Z, Kim JH, Brady SF (2010) Fluostatins produced by the heterologous expression of a TAR reassembled environmental DNA derived type II PKS gene cluster. J Am Chem Soc 132: 11902-11903.
36. Findlay B, Zhanel GG, Schweizer F (2010) Cationic amphiphiles, a new generation of antimicrobials inspired by the natural antimicrobial peptide scaffold. Antimicrob Agents Chemother 54: 4049-4058.
37. Flinspach K, Westrich L, Kaysser L, Siebenberg S, Gomez-Escribano JP, Bibb M, Gust B, Heide L (2010) Heterologous expression of the biosynthetic gene clusters of coumermycin A(1), clorobiocin and caprazamycins in genetically modified Streptomyces coelicolor strains. Biopolymers 93: 823-832.
38. Floss HG (2006) Combinatorial biosynthesis-potential and problems. J Biotechnol 124: 242-257.
39. Foley PL, Shuler ML (2010) Considerations for the design and construction of a synthetic platform cell for biotechnological applications. Biotechnol Bioeng 105: 26-36.
40. Forster J, Famili I, Fu P, Palsson BO, Nielsen J (2003) Genome-scale reconstruction of the saccharomyces cerevisiae metabolic network. Genome Res 13: 244-253.
41. Freitag A, Méndez C, Salas JA, Kammerer B, Li S-M, Heide L (2006) Metabolic engineering of the heterologous production of clorobiocin derivatives and elloramycin in Streptomyces coelicolor M512. Metab Eng 8: 653-661.
42. Fussenegger M, Morris RP, Fux C, Rimann M, von Stockar B, Thompson CJ, Bailey JE (2000) Streptogramin-based gene regulation systems for mammalian cells. Nat Biotechnol 18: 1203-1208.
43. Gao H, Zhuo Y, Ashforth E, Zhang L (2010) Engineering of a genome-reduced host: practical application of synthetic biology in the overproduction of desired secondary metabolites. Protein Cell 1: 621-626.
44. Gonzalez-Lergier J, Broadbelt LJ, Hatzimanikatis V (2006) Analysis of the maximum theoretical yield for the synthesis of erythromycin precursors in Escherichia coli. Biotechnol Bioeng 95: 638-644.
45. Gonzalez-Nicolini V, Fux C, Fussenegger M (2004) A novel mammalian cell-based approach for the discovery of anticancer drugs with reduced cytotoxicity on non-dividing cells. Invest New Drugs 22: 253-262.
46. Gossen M, Bujard H (1992) Tight control of gene expression in mammalian cells by tetracyclineresponsive promoters. Proc Natl Acad Sci U S A 89: 5547-5551.
47. Gruenewald S, Mootz HD, Stehmeier P, Stachelhaus T (2004) In vivo production of artificial nonribosomal peptide products in the heterologous host Escherichia coli. Appl Environ Microbiol 70: 3282-3291.
48. Haseltine EL, Arnold FH (2007) Synthetic gene circuits: design with directed evolution. Annu Rev Biophys Biomol Struct 36: 1-19.
49. Herrgard MJ, Swainston N, Dobson P, Dunn WB, Arga KY, Arvas M, Bluthgen N, Borger S, Costenoble R, Heinemann M, Hucka M, Le Novere N, Li P, Liebermeister W, Mo ML, Oliveira AP, Petranovic D, Pettifer S, Simeonidis E, Smallbone K, Spasic I, Weichart D, Brent R, Broomhead DS, Westerhoff HV, Kirdar B, Penttila M, Klipp E, Palsson BO, Sauer U, Oliver SG, Mendes P, Nielsen J, Kell DB (2008) A consensus yeast metabolic network reconstruction obtained from a community approach to systems biology. Nat Biotechnol 26: 1155-1160.
50. Isaacs FJ, Carr PA, Wang HH, Lajoie MJ, Sterling B, Kraal L, Tolonen AC, Gianoulis TA, Goodman DB, Reppas NB, Emig CJ, Bang D, Hwang SJ, Jewett MC, Jacobson JM, Church GM (2011) Precise manipulation of chromosomes in vivo enables genome-wide codon replacement. Science 333: 348-353.
51. Jung WS, Han AR, Hong JS, Park SR, Choi CY, Park JW, Yoon YJ (2007) Bioconversion of 12-, 14-, and 16-membered ring aglycones to glycosylated macrolides in an engineered strain of Streptomyces venezuelae. Appl Microbiol Biotechnol 76: 1373-1381.
52. Kang SJ, Won HS, Choi WS, Lee BJD (2009) Novo generation of antimicrobial LK peptides with a single tryptophan at the critical amphipathic interface. J Pept Sci 15: 583-588.
53. Kauffman KJ, Prakash P, Edwards JS (2003) Advances influx balance analysis. Curr Opin Biotechnol 14: 491-496.
54. Keasling JD (2010) Manufacturing molecules through metabolic engineering. Science 330: 1355-1358.
55. Kim JH, Feng Z, Bauer JD, Kallifidas D, Calle PY, Brady SF (2010) Cloning large natural product gene clusters from the environment: piecing environmental DNA gene clusters back together with TAR. Biopolymers 93: 833-844.
56. Komatsu M, Uchiyama T, Omura S, Cane DE, Ikeda H (2010) Genome-minimized streptomyces host for the heterologous expression of secondary metabolism. Proc Natl Acad Sci U S A 107: 2646-2651.
57. Kumarasamy KK, Toleman MA, Walsh TR, Bagaria J, Butt F, Balakrishnan R, Chaudhary U, Doumith M, Giske CG, Irfan S, Krishnan P, Kumar AV, Maharjan S, Mushtaq S, Noorie T, Paterson DL, Pearson A, Perry C, Pike R, Rao B, Ray U, Sarma JB, Sharma M, Sheridan E, Thirunarayan MA, Turton J, Upadhyay S, Warner M, Welfare W, Livermore DM, Woodford N (2010) Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study. Lancet Infect Dis 10: 597-602.
58. Lau J, Tran C, Licari P, Galazzo J (2004) Development of a high cell-density fed-batch bioprocess for the heterologous production of 6-deoxyerythronolide B in Escherichia coli. J Biotechnol 110: 95-103.
59. Lee SJ, Lee DY, Kim TY, Kim BH, Lee J, Lee SY (2005a) Metabolic engineering of Escherichia coli for enhanced production of succinic acid, based on genome comparison and in silico gene knockout simulation. Appl Environ Microbiol 71: 7880-7887.
60. Lee SY, Lee DY, Kim TY (2005b) Systems biotechnology for strain improvement. Trends Biotechnol 23: 349-358.
61. Lee J, Yun H, Feist AM, Palsson BO, Lee SY (2008) Genome-scale reconstruction and in silico analysis of the clostridium acetobutylicum ATCC 824 metabolic network. Appl Microbiol Biotechnol 80: 849-862.
62. Li X, Qin L (2005) Metagenomics-based drug discovery and marine microbial diversity. Trends Biotechnol 23: 539-543.
63. Li JW, Vederas JC (2009) Drug discovery and natural products: end of an era or an endless frontier? Science 325: 161-165.
64. Long PF, Dunlap WC, Battershill CN, Jaspars M (2005) Shotgun cloning and heterologous expression of the patellamide gene cluster as a strategy to achieving sustained metabolite production. ChemBioChem 6: 1760-1765.
65. Loose C, Jensen K, Rigoutsos I, Stephanopoulos G (2006) A linguistic model for the rational design of antimicrobial peptides. Nature 443: 867-869.
66. Mahadevan R, Edwards JS, Doyle FJ 3rd (2002) Dynamicflux balance analysis of diauxic growth in Escherichia coli. Biophys J 83: 1331-1340.
67. Martin VJJ, Pitera DJ, Withers ST, Newman JD, Keasling JD (2003) Engineering a mevalonate pathway in Escherichia coli for production of terpenoids. Nat Biotechnol 21: 796-802.
68. Medema MH, Breitling R, Bovenberg R, Takano E (2011) Exploiting plug-and-play synthetic biology for drug discovery and production in microorganisms. Nat Rev Micro 9: 131-137.
69. Meng HL, Lu Z, Wang Y, Wang X, Zhang S (2011a) In silico improvement of heterologous biosynthesis of erythromycin precursor 6-deoxyerythronolide B in Escherichia coli. Biotechnol Bioprocess Eng 16: 445-456.
70. Meng HL, Wang Y, Hua Q, Zhang SL, Wang XN (2011b) In silico analysis and experimental improvement of taxadiene heterologous biosynthesis in Escherichia coli. Biotechnol Bioprocess Eng 16: 205-215.
71. Menzella HG, Reid R, Carney JR, Chandran SS, Reisinger SJ, Patel KG, Hopwood DA, Santi DV (2005) Combinatorial polyketide biosynthesis by de novo design and rearrangement of modular polyketide synthase genes. Nat Biotechnol 23: 1171-1176.
72. Mizoguchi H, Mori H, Fujio T (2007) Escherichia coli minimum genome factory. Biotechnol Appl Biochem 46: 157-167.
73. Morrone D, Lowry L, Determan MK, Hershey DM, Xu M, Peters RJ (2010) Increasing diterpene yield with a modular metabolic engineering system in E. coli: comparison of MEV and MEP isoprenoid precursor pathway engineering. Appl Microbiol Biotechnol 85: 1893-1906.
74. Na D, Kim TY, Lee SY (2010) Construction and optimization of synthetic pathways in metabolic engineering. Curr Opin Microbiol 13: 363-370.
75. Neumann H, Neumann-Staubitz P (2010) Synthetic biology approaches in drug discovery and pharmaceutical biotechnology. Appl Microbiol Biotechnol 87: 75-86.
76. Oh YK, Palsson BO, Park SM, Schilling CH, Mahadevan R (2007) Genome-scale reconstruction of metabolic network in Bacillus subtilis based on high-throughput phenotyping and gene essentiality data. J Biol Chem 282: 28791-28799.
77. Olano C, Mendez C, Salas JA (2010) Post-PKS tailoring steps in natural product-producing actinomycetes from the perspective of combinatorial biosynthesis. Nat Prod Rep 27: 571-616.
78. Park Y, Lee DG, Jang SH, Woo ER, Jeong HG, Choi CH, Hahm KS (2003) A Leu-Lys-rich antimicrobial peptide: activity and mechanism. Biochim Biophys Acta 1645: 172-182.
79. Park JH, Lee KH, Kim TY, Lee SY (2007) Metabolic engineering of Escherichia coli for the production of L-valine based on transcriptome analysis and in silico gene knockout simulation. Proc Natl Acad Sci U S A 104: 7797-7802.
80. Pfeifer BA, Admiraal SJ, Gramajo H, Cane DE, Khosla C (2001) Biosynthesis of complex polyketides in a metabolically engineered strain of E. coli. Science 291: 1790-1792.
81. Pfleger BF, Pitera DJ, Smolke CD, Keasling JD (2006) Combinatorial engineering of intergenic regions in operons tunes expression of multiple genes. Nat Biotechnol 24: 1027-1032.
82. Picataggio S (2009) Potential impact of synthetic biology on the development of microbial systems for the production of renewable fuels and chemicals. Curr Opin Biotechnol 20: 325-329.
83. Powers J-PS, Hancock REW (2003) The relationship between peptide structure and antibacterial activity. Peptides 24: 1681-1691.
84. Prather KL, Martin CH (2008) De novo biosynthetic pathways: rational design of microbial chemical factories. Curr Opin Biotechnol 19: 468-474.
85. Price ND, Papin JA, Schilling CH, Palsson BO (2003) Genome-scale microbial in silico models: the constraints-based approach. Trends Biotechnol 21: 162-169.
86. Reed JL, Vo TD, Schilling CH, Palsson BO (2003) An expanded genome-scale model of Escherichia coli K-12 (iJR904 GSM/GPR). Genome Biol 4: R54.
87. Rix U, Fischer C, Remsing LL, Rohr J (2002) Modification of post-PKS tailoring steps through combinatorial biosynthesis. Nat Prod Rep 19: 542-580.
88. Rodriguez E, McDaniel R (2001) Combinatorial biosynthesis of antimicrobials and other natural products. Curr Opin Microbiol 4: 526-534.
89. Scherlach K, Hertweck C (2009) Triggering cryptic natural product biosynthesis in microorganisms. Org Biomol Chem 7: 1753-1760.
90. Segre D, Vitkup D, Church GM (2002) Analysis of optimality in natural and perturbed metabolic networks. Proc Natl Acad Sci U S A 99: 15112-15117.
91. Shao Z, Zhao H (2009) DNA assembler, an in vivo genetic method for rapid construction of biochemical pathways. Nucleic Acids Res 37: e16.
92. Shlomi T, Berkman O, Ruppin E (2005) Regulatory on/off minimization of metabolicflux changes after genetic perturbations. Proc Natl Acad Sci U S A 102: 7695-7700.
93. Singh J, Behal A, Singla N, Joshi A, Birbian N, Singh S, Bali V, Batra N (2009) Metagenomics: concept, methodology, ecological inference and recent advances. Biotechnol J 4: 480-494.
94. Sousa JC, Berto RF, Gois EA, Fontenele-Cardi NC, Honorio JE Jr, Konno K, Richardson M, Rocha MF, Camargo AA, Pimenta DC, Cardi BA, Carvalho KM (2009) Leptoglycin: a new glycine/leucine-rich antimicrobial peptide isolated from the skin secretion of the South American frog leptodactylus pentadactylus (leptodactylidae). Toxicon 54: 23-32.
95. Sprinzak D, Elowitz MB (2005) Reconstruction of genetic circuits. Nature 438: 443-448.
96. Thiele I, Vo TD, Price ND, Palsson BO (2005) Expanded metabolic reconstruction of helicobacter pylori (iIT341 GSM/GPR): an in silico genome-scale characterization of single-and doubledeletion mutants. J Bacteriol 187: 5818-5830.
97. Thiele I, Jamshidi N, Fleming RM, Palsson BO (2009) Genome-scale reconstruction of Escherichia coli 's transcriptional and translational machinery: a knowledge base, its mathematical formulation, and its functional characterization. PLoS Comput Biol 5: e1000312.
98. Tsuruta H, Paddon CJ, Eng D, Lenihan JR, Horning T, Anthony LC, Regentin R, Keasling JD, Renninger NS, Newman JD (2009) High-level production of amorpha-4, 11-diene, a precursor of the antimalarial agent artemisinin, in Escherichia coli. PLoS One 4: e4489.
99. Walter T (2010) Visualization of image data from cells to organisms. Nat Methods 7: S26-S40.
100. Wang HH, Isaacs FJ, Carr PA, Sun ZZ, Xu G, Forest CR, Church GM (2009) Programming cells by multiplex genome engineering and accelerated evolution. Nature 460: 894-898.
101. Weber W, Fux C, Daoud-el Baba M, Keller B, Weber CC, Kramer BP, Heinzen C, Aubel D, Bailey JE, Fussenegger M (2002) Macrolide-based transgene control in mammalian cells and mice. Nat Biotechnol 20: 901-907.
102. Weber CC, Link N, Fux C, Zisch AH, Weber W, Fussenegger M (2005) Broad-spectrum protein biosensors for class-specific detection of antibiotics. Biotechnol Bioeng 89: 9-17.
103. Weber W, Schoenmakers R, Keller B, Gitzinger M, Grau T, Daoud-El Baba M, Sander P, Fussenegger M (2008) A synthetic mammalian gene circuit reveals antituberculosis compounds. Proc Natl Acad Sci U S A 105: 9994-9998.
104. Weber T, Rausch C, Lopez P, Hoof I, Gaykova V, Huson DH, Wohlleben W (2009) CLUSEAN: a computer-based framework for the automated analysis of bacterial secondary metabolite biosynthetic gene clusters. J Biotechnol 140: 13-17.
105. Weissman KJ, Leadlay PF (2005) Combinatorial biosynthesis of reduced polyketides. Nat Rev Microbiol 3: 925-936.
106. Wenzel SC, Gross F, Zhang Y, Fu J, Stewart AF, Muller R (2005) Heterologous expression of a myxobacterial natural products assembly line in pseudomonads via red/ET recombineering. Chem Biol 12: 349-356.
107. Westfall PJ, Pitera DJ, Lenihan JR, Eng D, Woolard FX, Regentin R, Horning T, Tsuruta H, Melis DJ, Owens A, Fickes S, Diola D, Benjamin KR, Keasling JD, Leavell MD, McPhee DJ, Renninger NS, Newman JD, Paddon CJ (2012) Production of amorphadiene in yeast, and its conversion to dihydroartemisinic acid, precursor to the antimalarial agent artemisinin. Proc Natl Acad Sci U S A 109: E111-E118.
108. Wilkinson B, Micklefield J (2007) Mining and engineering natural-product biosynthetic pathways. Nat Chem Biol 3: 379-386.
109. Williams GJ, Goff RD, Zhang C, Thorson JS (2008) Optimizing glycosyltransferase specificity via "hot spot" saturation mutagenesis presents a catalyst for novobiocin glycorandomization. Chem Biol 15: 393-401.
110. Wingler LM, Cornish VW (2011) Reiterative recombination for the in vivo assembly of libraries of multigene pathways. Proc Natl Acad Sci U S A 108: 15135-15140.
111. Withers ST, Keasling JD (2007) Biosynthesis and engineering of isoprenoid small molecules. Appl Microbiol Biotechnol 73: 980-990.
112. Withers ST, Gottlieb SS, Lieu B, Newman JD, Keasling JD (2007) Identification of isopentenol biosynthetic genes from Bacillus subtilis by a screening method based on isoprenoid precursor toxicity. Appl Environ Microbiol 73: 6277-6283.
113. Wolpert M, Heide L, Kammerer B, Gust B (2008) Assembly and heterologous expression of the coumermycin A1 gene cluster and production of new derivatives by genetic engineering. ChemBioChem 9: 603-612.
114. Wyszynski FJ, Hesketh AR, Bibb MJ, Davis BG (2010) Dissecting tunicamycin biosynthesis by genome mining: cloning and heterologous expression of a minimal gene cluster. Chem Sci 1: 581-589.
115. Yadav G, Gokhale RS, Mohanty D (2009) Towards prediction of metabolic products of polyketide synthases: an in silico analysis. PLoS Comput Biol 5: e1000351.
116. Yin X, Chen Y, Zhang L, Wang Y, Zabriskie TM (2010) Enduracidin analogues with altered halogenation patterns produced by genetically engineered strains of Streptomyces fungicidicus. J Nat Prod 73: 583-589.
117. Zhang W, Tang Y (2008) Combinatorial biosynthesis of natural products. J Med Chem 51: 2629-2633.
118. Zhang Y, Buchholz F, Muyrers JP, Stewart AF (1998) A new logic for DNA engineering using recombination in Escherichia coli. Nat Genet 20: 123-128.
119. Zhang H, Wang Y, Pfeifer BA (2008) Bacterial hosts for natural product production. Mol Pharm 5: 212-225.
120. Zorko M, Jerala R (2010) Production of recombinant antimicrobial peptides in bacteria. Method Mol Biol 618: 61-76.